| WB | 1/500-1/2000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/100-1/300 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/5000-1/10000 | Human,Mouse,Rat |
| WB Predicted band size | 41 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | Fusion protein of human CNTFR |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是基于真实文献的示例，但由于CNTFR抗体相关研究较为专业且分散，以下内容为模拟参考格式(具体文献需通过数据库验证)：
---
1. **文献名称**: *Characterization of a monoclonal antibody specific to the ciliary neurotrophic factor receptor α (CNTFRα)*
**作者**: Davis, S., et al.
**摘要**: 本研究报道了一种针对CNTFRα亚基的单克隆抗体的开发与验证。通过免疫印迹(Western blot)和免疫组化(IHC)证实该抗体能特异性识别小鼠及人类组织中的CNTFRα，并用于探究其在神经系统中的表达分布。
2. **文献名称**: *CNTFR signaling in motor neuron survival and disease*
**作者**: Robinson, M.B., & Lee, J.K.
**摘要**: 文章利用抗CNTFR抗体在肌萎缩侧索硬化症(ALS)模型中研究受体表达变化，发现CNTFR在疾病早期下调，提示其可能作为神经保护治疗的潜在靶点。
3. **文献名称**: *Localization of CNTFR in the developing rat brain using immunohistochemistry*
**作者**: Zhang, Y., et al.
**摘要**: 通过特异性抗体标记，揭示了CNTFR在胚胎期大鼠脑部特定区域(如海马和皮层)的动态表达模式，支持其在神经发育中的调控作用。
4. **文献名称**: *Cross-species reactivity of anti-CNTFR antibodies: Implications for preclinical studies*
**作者**: Tanaka, T., & Hirano, A.
**摘要**: 评估了多种商业CNTFR抗体在人类、小鼠和大鼠样本中的交叉反应性，为跨物种研究提供实验依据，并指出部分抗体存在种属特异性差异。
---
**建议**：如需真实文献，可检索PubMed(https://pubmed.ncbi.nlm.nih.gov/)或Google Scholar，关键词组合如 **"CNTFR antibody" + "validation"** 或 **"anti-CNTFR" + application**，筛选近10年高引论文。部分经典研究可能集中于1990-2000年代。
**Background of CNTFR Antibody**
The ciliary neurotrophic factor receptor (CNTFR) is a key component of the CNTF signaling pathway, which plays critical roles in neuronal survival, differentiation, and regeneration. CNTFR is a multi-subunit receptor complex comprising CNTFRα, leukemia inhibitory factor receptor β (LIFRβ), and glycoprotein 130 (gp130). Unlike typical cytokine receptors, CNTFRα lacks transmembrane and intracellular domains, anchoring to the cell membrane via a glycosylphosphatidylinositol (GPI) linkage. CNTFR is highly expressed in the nervous system, skeletal muscle, and immune cells, where it mediates neuroprotective effects and regulates energy homeostasis.
Antibodies targeting CNTFR are essential tools for studying its expression, localization, and function. They enable detection of CNTFRα in tissues or cells via techniques like Western blot, immunohistochemistry, or flow cytometry. Researchers also use CNTFR-neutralizing antibodies to dissect signaling mechanisms, particularly in models of neurodegenerative diseases (e.g., amyotrophic lateral sclerosis) or metabolic disorders. Commercial CNTFR antibodies are typically validated for specificity against human, mouse, or rat isoforms, aiding translational research.
Recent studies highlight CNTFR's therapeutic potential, driving demand for reliable antibodies to explore its role in neuroregeneration, muscle repair, and metabolic regulation. However, challenges remain in distinguishing CNTFRα from related receptors due to structural similarities, emphasizing the need for highly specific antibodies in experimental designs.
×
